>NATIONAL LIST OF ESSENTIAL MEDICINES 2003

9 अप्रैल

>

Directorate General of Health Services
Ministry of Health & Family Welfare
Government of India
lR;eso t;rs

Contents
List of Participants i
Preface to National List of Essential Medicines 2003 ii
Preface to National Essential Drugs List 1996 v
List of Additions viii
List of Omissions x
List of Drug Movements Across Categories xi
Therapeutic Categories xii
List of Essential Medicines
1. Anaesthetics 1
1.1 General Anaesthetics and Oxygen 1
1.2 Local Anaesthetics 1
1.3 Preoperative Medication and Sedation for 1
Short Term Procedures
1.4 Postoperative Respiratory Stimulant 2
2. Analgesics, Antipyretics, Nonsteroidal Antiinflammatory 2
Medicines, Medicines used to treat Gout and Disease Modifying
Agents used in Rheumatoid Disorders
2.1 Non-Opioid Analgesics, Antipyretics and Nonsteroidal 2
Antiinflammatory Medicines
2.2 Opioid Analgesics 2
2.3 Medicines used to treat Gout 2
2.4 Disease Modifying Agents used in Rheumatoid Disorders 3
3. Antiallergics and Medicines used in Anaphylaxis 3
4. Antidotes and Other Substances used in Poisonings 3
4.1 Nonspecific 3
4.2 Specific 4
5. Anticonvulsants/Antiepileptics 4
6. Antiinfective Medicines 5
6.1 Anthelminthics 5
6.1.1 Intestinal Anthelminthics 5
6.1.2 Antifilarials 5
6.1.3 Antischistosomals and Antitrematode Medicines 5
6.2 Antibacterials 5
6.2.1 Beta Lactam Medicines 5
6.2.2 Other Antibacterials 6
6.2.3 Antileprosy Medicines 7
6.2.4 Antituberculosis Medicines 8
6.3 Antifungal Medicines 8
6.4 Antiviral Medicines 9
6.4.1 Antiherpes Medicines 9
6.4.2 Antiretroviral Medicines* 9
6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors 9
6.4.2.2 Non-nucleoside Reverse Transcriptase Inhibitors 9
6.4.2.3 Protease Inhibitors 9
6.5 Antiprotozoal Medicines 10
6.5.1 Antiamoebic and Antigiardiasis Medicines 10
6.5.2 Antileishmaniasis Medicines 10
6.5.3 Antimalarial Medicines 10
6.5.3.1 For Curative Treatment 10
6.5.3.2 For Prophylaxis 11
6.5.4 Antipneumocystosis and Antitoxoplasmosis Medicines 11
7. Antimigraine Medicines 11
7.1 For Treatment of Acute Attack 11
7.2 For Prophylaxis 11
8. Antineoplastic, Immunosuppressives and Medicines 12
used in Palliative Care
8.1 Immunosuppressive Medicines 12
8.2 Cytotoxic Medicines 12
8.3 Hormones and Antihormones 13
8.4 Medicines used in Palliative Care 14
9. Antiparkinsonism Medicines 14
10. Medicines affecting the Blood 14
10.1 Antianemia Medicines 14
10.2 Medicines Affecting Coagulation 15
11. Blood Products and Plasma Substitutes 15
11.1 Plasma Substitutes 15
11.2 Plasma Fractions for Specific Use 15
12. Cardiovascular Medicines 16
12.1 Antianginal Medicines 16
12.2 Antiarrhythmic Medicines 16
12.3 Antihypertensive Medicines 17
12.4 Medicines used in Heart Failure 18
12.5 Antithrombotic Medicines 18
13. Dermatological Medicines (Topical) 18
13.1 Antifungal Medicines 18
13.2 Antiinfective Medicines 18
13.3 Antiinflammatory and Antipruritic Medicines 19
13.4 Astringent Medicines 19
13.5 Medicines Affecting Skin Differentiation and Proliferation 19
13.6 Scabicides and Pediculicides 19
14. Diagnostic Agents 19
14.1 Ophthalmic Medicines 19
14.2 Radiocontrast Media 20
15. Disinfectants and Antiseptics 20
15.1 Antiseptics 20
15.2 Disinfectants 21
16. Diuretics 21
17. Gastrointestinal Medicines 21
17.1 Antacids and other Antiulcer Medicines 21
17.2 Antiemetics 22
17.3 Antihaemorrhoidal Medicines 22
17.4 Antiinflammatory Medicines 22
17.5 Antispasmodic Medicines 22
17.6 Laxatives 22
17.7 Medicines used in Diarrhoea 23
17.7.1 Oral Rhydration Salts 23
17.7.2 Antidiarrhoeal Medicines 23
18. Hormones, other Endocrine Medicines and Contraceptives 23
18.1 Adrenal Hormones and Synthetic Substitutes 23
18.2 Androgens 23
18.3 Contraceptives 23
18.3.1 Hormonal Contraceptives 23
18.3.2 Intrauterine Devices 24
18.3.3 Barrier Methods 24
18.3.4 Non Hormonal Contraceptives 24
18.4 Estrogens 24
18.5 Antidiabetics and Hyperglycaemics 24
18.5.1 Insulins and Other Antidiabetic Agents 24
18.5.2 Hyperglycaemics 24
18.6 Ovulation Inducers 24
18.7 Progestogens 24
18.8 Thyroid and Antithyroid Medicines 25
19. Immunologicals 25
19.1 Diagnostic Agents 25
19.2 Sera and Immunoglobulins 25
19.3 Vaccines 25
19.3.1 For Universal Immunisation 25
19.3.2 For Specific Group of Individuals 26
20. Muscle Relaxants (peripherally acting) and Cholinesterase Inhibitors 26
21. Ophthalmological Preparations 26
21.1 Antiinfective Agents 26
21.2 Antiinflammatory Agents 27
21.3 Local Anaesthetics 27
21.4 Miotics and Antiglaucoma Medicines 27
21.5 Mydriatics 27
21.6 Ophthalmic Surgical Aids 27
22. Oxytocics and Antioxytocics 27
22.1 Oxytocics 27
22.2 Antioxytocics 27
23. Peritoneal Dialysis Solution 28
24. Psychotherapeutic Medicines 28
24.1 Medicines used in Psychotic Disorders 28
24.2 Medicines used in Mood Disorders 28
24.2.1 Medicines used in Depressive Disorders 28
24.2.2 Medicines used in Bipolar Disorders 28
24.3 Medicines used for Generalized Anxiety and Sleep Disorders 28
24.4 Medicines used for Obsessive Compulsive Disorders and 29
Panic Attacks
25. Medicines Acting on the Respiratory Tract 29
25.1 Antiasthmatic Medicines 29
25.2 Antitussives 29
26. Solutions correcting Water, Electrolyte, and Acid-Base Disturbances 29
26.1 Oral 29
26.2 Parenteral 30
26.3 Miscellaneous 30
27. Vitamins and Minerals 30
Index 31
List of Participants in the preparation of National
List of Essential Medicines
(i) Dr. S. D. Seth, Chairman
(ii) Mr. Ashwini Kumar, Member Secretary
(iii) Dr. Y. K. Gupta, Prof. of Pharmacology, AIIMS Member
(iv) Dr. C. P. Singh, M. S., RML Hospital Member
(v) Dr. Y. N. Rao, DDG(M) Member
(vi) Dr. Sandeep Guleria, AIIMS Member
(vii) Dr. P. L. Joshi, Addl. Project Director, NACO Member
(viii) Dr. G. P. Sinha, Prof. of Medicine, Patna Medical College Member
(ix) Dr. J. N. Pandey, HOD (Medicine), AIIMS Member
(x) Dr. G. K. Biswas, Addl. DG (Stores) Member
(xi) Dr. Nikita Gupta Kamal Member
(xii) Dr. Rita Sood (co-opted) Member
(xiii) Dr. R.N. Salhan (co-opted in April 2003) Member
(xiv) Dr. Usha Gupta (co-opted in December 2002) Member
(xv) Mr. Brijesh Regal, WHO Consultant in DCG(I) office Coordinator
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
i
ii
Preface to National List of Essential Medicines 2003
The review of National Essential Drugs List 1996, was due in the context of
contemporary knowledge of the therapeutic products. An expert core committee was
constituted by the Director General of Health Services in June 2002 for this purpose.
The committee comprised of the following members:
1. Dr. Y. K. Gupta, Prof. of Pharmacology, AIIMS, New Delhi
2. Dr. C. P. Singh, Medical Suprintendant, RML Hospital, New Delhi
3. Dr. Y. N. Rao, DDG(M), DteGHS, MOHFW, New Delhi
4. Dr. Sandeep Guleria, AIIMS, New Delhi
5. Representative from ICMR, New Delhi
6. Representative from NACO, New Delhi
7. Dr. G. P. Sinha, Prof. of Medicines, Patna Medical College, Patna
8. Dr. J. N. Pandey, HOD (Medicines), AIIMS, New Delhi
9. Dr. G. K. Biswas, Addl. DG (Stores), DteGHS, MOHFW, New Delhi
10. Dr. Nikita Gupta Kamal, Ophthalmologist
11. Mr. Brijesh Regal, WHO Consultant in DCG(I) office
12. Mr. Ashwini Kumar, DCG(I), DteGHS, MOHFW, New Delhi
Dr. S. D. Seth, Chair in Clinical Pharmacology, ICMR represented ICMR on the
committee and was nominated by members to be the Chairman of the core committee.
Dr. J. N. Pandey nominated Dr. Rita Sood, Addl. Prof. of Medicine, AIIMS to participate
in the committee’s delibrations. Dr. R. N. Salhan, Medical Suprintendant, RML Hospital
contributed as member of the core committee, consequent to the retirement of
Dr. C. P. Singh.
Dr. P. L. Joshi was nominated by NACO as member of the committee. Dr. Usha Gupta,
HOD Pharmacology, MAMC was coopted as member of the committee.
After detailed delibrations in its first meeting, the committee agreed on the following
criteria for identifying medicines for inclusion in the revised list:
• Consideration of relevant disease burden in the country
• Information on the efficacy, safety and comparative cost effectiveness of
the products
• Preference for single active compounds
• Cost effectiveness in the context of cost of treatment
• Available health delivery infrastructure (e.g. treatment facilities, training
and experience of the available personnel; availability, financial
resources; and environmental factors etc.)
Addition of drugs required in emergency care/life threatening situations were also
considered. The committee also decided to follow the principles and concepts of
“Essential” drugs as enunciated by WHO, as was done for the 1996 list. Accordingly,
the description of the list as ‘Essential Medicines’ List was adopted and includes three
components: a definition, a description of the selection criteria and a description of the
iii
purpose for which such a list is developed, as follows:
Definition: Essential medicines are those that satisfy the priority health care needs of the
population.
Selection criteria: Essential medicines are selected with due regard to disease
prevalence, evidence on efficacy and safety, and comparative cost-effectiveness.
Purpose: Essential medicines are intended to be available within the context of
functioning health systems at all times in adequate amounts, in the appropriate dosage
forms, with assured quality. Evidently, the word “Essential” does not purport to convey
that number of other drugs available in the market are non-essential.
Several sub-committees of clinicians were formed to review the various sub-groups of
medicines and core committee members coordinated the proceedings of one or more of
these respective sub groups. Each of these sub-group members, and indeed all those
who provided their professional inputs, were clearly explained about the fundamental
doctorine of the “essential” medicine’s description as stated above.
The medicines that have finally been included in this list have gone through several
intensive screenings by the expert group as well as by invited and consulted
professionals. Cost of therapy was worked out especially in the context of already
available therapies and keeping in view the drugs available for these categories in the
WHO list of essential medicines. Essential Drugs List of various states and WHO Model
Formulary (2002) were also referred during the review process. Medicines used by
various national programmes and emergency care drugs etc. which were earlier
identified by health care professionals in the context of drug policy, were also
considered.
A new section on medicines for HIV-AIDS has been included since it was non-existent in
the 1996 list. Several new anti-cancer drugs have been added in the current list.
Additional drugs find place in the revised list.
The committee is of the opinion that since the word ‘drug’ is now globally considered to
have a different (narcotic) connotation, it may be replaced with the word ‘Medicine’ a
term which is now more widely used to describe therapeutic pharmaceutical
substances. WHO has also renamed its list as Model List of Essential “Medicines”.
Accordingly, the present list has been titled “National List of Essential Medicines”.
The committee gratefully acknowledges the contributions made by the following
experts:
Dr. M. P. Sharma, Dr. Praveen Aggarwal, Dr. Nikhil Tandon, Dr. P. P. Kotwal, Dr. Arvind
Kumar, Dr. Sunesh Kumar, Dr. Rakesh Yadav, Dr. S. K. Maulik, Dr. S. C. Tiwari, Dr. Ravi
Saksena, Dr. Renu Saxena, Dr. Kaushal K. Verma.
Categories of the medicines as classified in NEDL 1996 have been revised to
harmonize with the latest “Sections” used by WHO Essential Medicines List. Although
WHO has published two separate lists in its latest revision (core list and complementary
iv
list) the committee has taken a conscious decision to keep the core and complementary
medicines together in the main list itself. The complementary medicines have been
marked * and denote those medicines which may be needed when other medicines
listed in the category are not readily available or they may be required in specific
situations or locations for well founded reasons.
The committee observed that critical care or emergency care medicines are many times
perceived as “life saving drugs” though this is not a standard terminology in the context of
overall use of medicinal products. It would be seen that the essential medicines list
consists of medicines meant for the management of a wide variety of conditions ranging
from symptomatic relief, public health care, management of infections as well as for “life
threatening” – emergency situations & for critical care.
An index of therapeutic categories has been included in the final version for ease of
reference. The nomenclature of medicines has been made consistent with that used in
India [e.g. Epinephrine has been changed to Adrenaline and first letters of names of the
medicines have been made capital, as in Indian Pharmacopoeia (I.P.)].
It is felt that this list may be reviewed every two years to keep it relevant in the context of
contemporary knowledge and drugs that keep appearing on the horizon.
The committee gratefully acknowledges the support provided by WHO-India Country
Office for the review process as well as for dissemination of this list.
Preface to National Essential Drugs List 1996
1. The Ministry of Health, Government of India, is pleased to introduce the National
Essential Drugs List for adoption in the country. The list is modelled on the WHO
Essential Drugs List, and follows the general principles enunciated by WHO in
the preparation of such lists.
2. In India, healthcare is provided by both Private and Public Sectors. It is the
responsibility of the Public Sector to establish healthcare institutions accessible
to all sections of the population in all parts of the country, to provide diagnostic
and treatment facilities. However, the state has not accepted the responsibility of
supplying the entire requirement of drugs to treat all the patients receiving
treatment in state-funded institutions. At the levels of Central and State
Governments, medicines are supplied free of cost or against token payment to
the government employees, and free of cost to the weaker section of the
population who avail of the treatment facilities provided by the Government
through primary, secondary or tertiary levels of state healthcare institutions.
Through different National Programmes for the control of diseases of high
morbidity and endemicity drugs are also supplied to effect a cure to all patients
who approach the treatment centres established under such programmes.
3. The National Essential Drugs List implies that the drugs included in it are
adequate to meet the common contemporary health needs of the general
population of the country and general obligation of the health administrators to
ensure abundant availability of such drugs in the country. The drugs included in
this list are generally safe and effective, and are approved by the Drugs
Controller General, India, and are currently available at affordable prices to the
general public.
4. The exclusion in the National List of any drug which is currently available and
recommended by the physicians does not imply that they are less effective or
unsuitable to the Indian patients. Their exclusion may have been influenced by
one or more of the following factors-cost benefit ratio, dependence on imports or
imported raw materials, indicated in the treatment of diseases not considered
significant in the National context, insufficient experience with the drug in India,
not approved for use in the specific indication by the Drugs Controller General,
India, or for which no standard is approved under the Drugs & Cosmetics Act and
Rules. The safety, efficacy and quality of the drugs currently available in India are
according to the standards prescribed in India and the exclusion of any drug from
this list does not mean that it is less effective in comparison to any alternative
drug which has found its place in the list.
5. The national list is not intended as an imposition on the rights of state
governments, government institutions, or private health care providers. It is
meant to be used as a guideline to the concept of rational therapeutics and as an
indicator of availability in the country. While the drugs selected are considered
adequate to treat diseases common to most parts of the country, it is appreciated
that specific regional requirements for drugs to treat diseases of local importance
v
vi
may not be available in the National List, and in such instances it will be
appropriate for the state health administration (adopting the National List) to
include drugs as may be considered adequate to treat these diseases.
6. A committee of experts was constituted by the DGHS in February, 1996, to
prepare the National Essential Drugs List. This committee selected a core group
comprising of:
Dr. P. Das Gupta
Dr. S. D. Seth
Dr. C. B. Sridhar
Dr. M. R. Samuel
Dr. J. N. Mohanty
Dr. G. K. Biswas
Dr. J. S. Bapna
to prepare a preliminary list. The core group took note of the procurement of State
Governments, different Central Government institutions (e.g. CGHS, ESIC,
GMSD, etc.) and WHO Essential Drugs List. The tentative list was subjected to
scrutiny for therapeutic efficacy, availability and cost-effectiveness by the core
group in consultation with experts in different disciplines of medicine. The draft
was finally adopted in the meeting of experts held on 4th April, 1996.
7. The list is intended to be a dynamic document, subject to change, with addition
and/or deletions, as medical knowledge advances and new drugs become
available at remunerative pricing. The list uses generic names for scientific
clarity.
8. For convenience and ease of comparison, the same category numbers and
headings have been used as in the WHO Model List (1995). However, only the
names of the active bases have been used, avoiding the mention of salts or
esters, e.g. morphine instead of morphine sulphate. The quantity mentioned in
the strength of the dosage forms refers to the base unless by established practice
or by pharmacopoeial standard it refers to the salt or the ester. The quality control
standards are as in Indian Pharmacopoeia unless the drug is not included in I.P.
9. Drugs marked with an asterisk (*) are to be considered as complementary drugs,
i.e. those that are used if the other drugs in the category are not available or they
are required for specific patients, situations or locations for valid reasons.
10. The names of drugs are followed by the following letters to indicate their need at
various levels of medical care:
P Primary health care
S Secondary health care
T Tertiary health care
U Universal
11. Although the drugs are listed by therapeutic categories, these are not necessarily
meant to be used as prescribing guidelines. A drug that may deserve to be
vii
included in a particular category may not be found in the category as it may
already be included in another category.
Acknowledgement
Our acknowledgements are due to Dr. Annapurna Rao, Dr. Ranjit Ray Chowdhury, Mr.
Adeep Bagati, Dr. M. R. Samuel, Dr. S. D. Seth and Dr. J. S. Bapna for their valuable
assistance and time to enable this first National Essential Drugs List to come out in such
a short time. We are grateful to SEARO, WHO for their guidance and financial help for
printing this list.
Dr. P. Das Gupta
Member-Secretary
Expert Committee
New Delhi
April 22, 1996
A list of items not included in the 1996 edition but added in
this edition is given below:
1. Adenosine 12.2
2. Alpha Interferon 8.2
3. Alprazolam 24.3
4. Artesunate 6.5.3.1
5. Azithromycin 6.2.2
6. Betaxolol Hydrochloride 21.4
7. Bretylium Tosylate 12.2
8. Bromocriptine Mesylate 9.0
9. Calcium Gluconate 4.2
10. Cefotaxime 6.2.1
11. Ceftadizidime 6.2.1
12. Ceftriaxone 6.2.1
13. Cefuroxime 6.2.1
14. Clarithromycin 6.2.2
15. Clomiphene Citrate 18.6
16. Clonidine Hydrochloride 12.3
17. Clotrimazole 6.3
18. Colchicine 2.3
19. Cryoprecipitate 11.2
20. Dexchlorpheniramine Maleate 3
21. Didanosine 6.4.2.1
22. Doxapram 1.4
23. Efavirenz 6.4.2.2
24. Esmolol 12.2
25. Fluconazole 6.3
26. Flumazenil 4.2
27. Flucytosine 6.3
28. Flutamide 8.2
29. Fresh Frozen Plasma 11.1
30. Gemcitabine Hydrochloride 8.2
31. Glucagon 18.5.2
32. Hormone Releasing IUD 18.3.1
33. Indinavir 6.4.2.3
34. Lamivudine + Nevirapine + Stavudine 6.4.2.1
35. Lamivudine + Zidovudine 6.4.2.1
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Sl. No. Name of the Drug Category
viii
36. Lamivudine 6.4.2.1
37. Losartan Potassium 12.3
38. Magnesium Sulphate 5
39. Medroxy Progesterone Acetate 18.7
40. Methyl Cellulose
41. Metoprolol 12.1
42. Midazolam 1.3
43. Mifepristone 22.1
44. N/2 Saline 26.2
45. N/5 Saline 26.2
46. Nelfinavir 6.4.2.3
47. Nevirapine 6.4.2.2
48. Nitrazepam 24.3
49. Odansetron 8.4
50. Ofloxacin 6.2.4
51. Omeprazole 17.1
52. Paclitaxel 8.2
53. Physostigmine Salicylate 21.4
54. Platelet Rich Plasma 11.2
55. Potassium Chloride 26.2
56. Pyridostigmine Bromide 20
57. Pyrimethamine 6.5.3.1
58. Raloxifene 8.3
59. Ritonavir 6.4.2.3
60. Roxithromycin 6.2.2
61. Saquinavir 6.4.2.3
62. Sodium Bicarbonate 26.2
63. Stavudine 6.4.2.1
64. Sulphadiazine 6.2.2
65. Terazosin 12.3
66. Thiacetazone + Isoniazid 6.2.4
67. Trifluoperazine 24.1
68. Trimethoprim 6.5.4
69 Vancomycin Hydrochloride 6.2.2
70. Zidovudine 6.4.2.1
71. Zinc Oxide 13.4
Sl. No. Name of the Drug Category
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
ix
A list of items included in the 1996 edition but not included
in this edition is given below:
1. Biperiden 9
2. Ethnylestradiol + Norgestrel 18.3
3. Neomycin 6.2.2
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Sl. No. Name of the Drug Category
x
xi
List of drug movements across categories
1. Acetyl Salicylic Acid 12.6 12.5
2. Acyclovir 6.5 6.4.1
3. Allopurinol 2.1 2.3
4. Amitriptyline 24.2 24.2.1
5. B.C.G Vaccine 19.3 19.3.1
6. Centchroman 18.3 18.3.4
7. D.P.T Vaccine 19.3 19.3.1
8. Diloxanide Furoate 6.4.1 6.5.1
9. Dobutamine 12.5 12.4
10. Dopamine 12.5 12.4
11. Ethinylestradiol + Levonorgestrel 18.3 18.3.1
12. Ethinylestradiol + Norethisterone 18.3 18.3.1
13. Fluoxetine 24.2 24.2.2
14. Furazolidone 17.7 17.7.2
15. Hepatitis B Vaccine 19.3 19.3.1
16. Imipramine 24.2 24.2.1
17. IUD Containing Copper 18.3 18.3.2
18. Loperamide 17.7 17.7.2
19. Measles Vaccine 19.3 19.3.1
20. Metronidazole 6.4.1 6.5.1
21. Oral Poliomyelitis Vaccine 19.3 19.3.1
22. Oral Rehydration Salts 17.7 17.7.1
23. Pentamidine 6.4.2 6.5.2
24. Praziquantel 6.1.1 6.1.3
25. Rabies Vaccine 19.3 19.3.2
26. Sodium Stibogluconate 6.4.2 6.5.2
27. Streptokinase 12.6 12.5
28. Sulphadoxine + Pyrimethamine 6.4.3 6.5.3.2
29. Tetanus Toxoid 19.3 19.3.2
30. Tinidazole 6.4.1 6.5.1
31. Urokinase 12.6 12.5
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Sl. No. Name of the Drug Category
From To
Therapeutic Categories
1. Anaesthetics 1
2. Analgesics, Antipyretics, Nonsteroidal Antiinflammatory 2
Medicines, Medicines used to treat Gout and Disease
Modifying Agents used in Rheumatoid Disorders.
3. Antiallergics and Medicines used in Anaphylaxis 3
4. Antidotes and Other Substances used in Poisonings 3
5. Anticonvulsants/Antiepileptics 4
6. Antiinfective Medicines 5
7. Antimigraine Medicines 11
8. Antineoplastic, Immunosuppressives and Medicines 12
used in Palliative Care
9. Antiparkinsonism Medicines 14
10. Medicines affecting the Blood 14
11. Blood Products and Plasma Substitutes 15
12. Cardiovascular Medicines 16
13. Dermatological Medicines (Topical) 18
14. Diagnostic Agents 19
15. Disinfectants and Antiseptics 20
16. Diuretics 21
17. Gastrointestinal Medicines 21
18. Hormones, other Endocrine Medicines and Contraceptives 23
19. Immunologicals 25
20. Muscle Relaxants (peripherally acting) and 26
Cholinesterase Inhibitors
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Sl. No. Therapeutic Category Page No.
xii
21. Ophthalmological Preparations 26
22. Oxytocics and Antioxytocics 27
23. Peritoneal Dialysis Solution 28
24. Psychotherapeutic Medicines 28
25. Medicines Acting on the Respiratory Tract 29
26. Solutions correcting Water, Electrolyte, and 29
Acid-Base Disturbances
27. Vitamins and Minerals 30
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Sl. No. Therapeutic Category Page No.
xiii

NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
1
1. Anaesthetics
1.1 General Anaesthetics and Oxygen
Ether, Anaesthetic S, T Inhalation
Halothane S, T Inhalation
Isoflurane* S, T Inhalation
Ketamine U Injection 10 mg / ml
Hydrochloride 50 mg / ml
Nitrous Oxide U Inhalation
Oxygen U Inhalation
Thiopentone SodiumS, T Injection 0.5 g,
1 g powder
1.2 Local Anaesthetics
Bupivacaine S, T Injection 0.25%,
Hydrochloride 0.5%
0.5% +
7.5% Glucose
Ethyl Chloride U Spray 1%
Lignocaine U Topical Forms 2-5%
Hydrochloride Injection 1-2%
Spinal 5% +
7.5% Glucose
Lignocaine U Injection 1%, 2% +
Hydrochloride + Adrenaline
Adrenaline 1:200,000
In vial
1.3 Preoperative Medication and Sedation for Short Term Procedures
Atropine Sulphate U Injection 0.6 mg / ml
Diazepam U Tablets 5 mg
Injection 5 mg / ml
* Complementary
Midazolam U Injection 1 mg / ml
5 mg / ml
Morphine Sulphate S, T Injection 10 mg / ml
Promethazine U Syrup 5 mg / 5 ml
1.4 Postoperative Respiratory Stimulant
Doxapram* T Injection 4 mg / ml
2. A n a l g e s i c s , A n t i p y r e t i c s , N o n s t e r o i d a l
Antiinflammatory Medicines, Medicines used to treat
Gout and Disease Modifying Agents used in
Rheumatoid Disorders.
2.1 Non-Opioid Analgesics, Antipyretics and Nonsteroidal Antiinflammatory
Medicines
Acetyl Salicylic Acid U Tablets 300 – 350 mg
Diclofenac T Tablets 50 mg,
100 mg
Injection 25 mg / ml
Ibuprofen U Tablets 200 mg,
400 mg
Paracetamol U Injection 150 mg / ml
Syrup 125 mg / 5ml
Tablets 500 mg
2.2 Opioid Analgesics
Morphine S, T Injection 10 mg / ml
Sulphate Tablets 10 mg
Pentazocine S, T Tablets 25 mg,
Injection 30 mg / ml
Pethidine S, T Injection 50 mg / ml
Hydrochloride
2.3 Medicines used to treat Gout
Allopurinol S, T Tablets 100 mg
Colchicine S, T Tablets 0.5 mg
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
2 * Complementary
2.4 Disease Modifying Agents used in Rheumatoid Disorders
Azathioprine S, T Tablets 50 mg
Chloroquine S, T Tablets 150 mg
Phosphate
Methotrexate S, T Tablets 2.5 mg
Sulfasalazine S, T Tablets 500 mg
3. Antiallergics and Medicines used in Anaphylaxis
Adrenaline U Injection 1 mg / ml
Bitartrate
Chlorpheniramine U Tablets 4 mg
Maleate
Dexchlorpheniramine Syrup 0.5 mg / 5 ml
Maleate
Dexamethasone U Tablets 0.5 mg
Injection 4 mg / ml
Hydrocortisone
Sodium Succinate U Injection 100 mg
Pheniramine U Injection 22.75 mg / ml
Maleate
Prednisolone S Tablets 5 mg
Promethazine U Tablets 10 mg, 25 mg
Syrup 5 mg / 5 ml
4. Antidotes and Other Substances used in Poisonings
4.1 Nonspecific
Activated Charcoal U Powder
Atropine Sulphate U Injection 0.6 mg / ml
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
3
4.2 Specific
Antisnake Venom U Injection Polyvalent
Solution/
Lyophilyzed Polyvalent
Serum
Calcium Gluconate S,T Injection 100 mg / ml
Desferrioxamine S, T Injection 500 mg
Mesylate
Dimercaprol S, T Injection in oil 50 mg / ml
Flumazenil* T Injection 0.1 mg / ml
Methylthioninium S, T Injection 10 mg / ml
Chloride
(Methylene blue)
Naloxone S, T Injection 0.4 mg / ml
Penicillamine S, T Tablets or Capsules 250 mg
Pralidoxime S, T Injection 25 mg / ml
Chloride (2-PAM)
Sodium Nitrite S, T Injection 30 mg / ml
Sodium
Thio S, T Injection 250 mg/ ml
5. Anticonvulsants/Antiepileptics
Carbamazepine U Tablets 100 mg,
200 mg
Syrup 20 mg / ml
Diazepam U Injection 5 mg / ml
Magnesium T Injection 500 mg /ml
Sulphate
Phenobarbitone U Tablets 30 mg,
60 mg
ST Injection 200 mg / ml
Phenytoin Sodium U Capsules or Tablets 50 mg,
100 mg
Syrup 25 mg / ml
Injection 50 mg / ml
sulphate
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
4 * Complementary
Sodium Valproate U Tablets 200 mg,
500 mg
Syrup 200 mg / 5 ml
6. Antiinfective Medicines
6.1 Anthelminthics
6.1.1 Intestinal Anthelminthics
Albendazole U Tablets 400 mg
Suspension 200 mg/ 5 ml
Mebendazole U Tablets 100 mg
Suspension 100 mg / 5 ml
Niclosamide U Chewable Tablets 500 mg
Pyrantel Pamoate U Tablets 250 mg
Suspension 250 mg / 5 ml
6.1.2 Antifilarials
Diethylcarbamazine U Tablets 50 mg
Citrate
6.1.3 Antischistosomals and Antitrematode Medicines
Praziquantel S, T Tablets 600 mg
6.2 Antibacterials
6.2.1 Beta Lactam Medicines
Amoxicillin U Powder for suspension 125 mg / 5 ml
Capsules 250 mg
500 mg
Ampicillin U Capsules 250 mg,
500 mg
Powder for suspension 125 mg / 5 ml
Injection 500 mg
Benzathine
Benzylpenicillin U Injection 6 lacs, 12 lacs,
24 lacs units
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
5
Benzylpenicillin U Injection 5 lacs,
10 lacs units
Cefotaxime* S, T Injection 125 mg,
250 mg,
500 mg
Ceftazidime* S, T Injection 250mg, 1g
Ceftriaxone* S, T Injection 250 mg, 1 g
Cefuroxime* S, T Injection 250 mg,
750 mg
Cloxacillin U Capsules 250 mg,
500 mg
Injection 250 mg
Liquid 125 mg / 5 ml
Procaine
Benzylpenicillin U Injection Crystalline
penicillin
(1 lac units) +
Procaine
penicillin
(3 lacs units)
6.2.2 Other Antibacterials
Amikacin S, T Injection 250 mg / 2 ml
Azithromycin* S, T Capsules or Tablets 100 mg,
250 mg,
500 mg
Suspension 100 mg / 5 ml
Injection 500 mg
Cephalexin U Syrup 125 mg / 5 ml
Capsules 250 mg,
500 mg
Clarithromycin* S, T Capsules 500 mg
Chloramphenicol S, T Injection 1 g
S, T Suspension 125 mg / 5 ml
S, T Capsules, Tablets 250 mg,
500 mg
Ciprofloxacin U Injection 200 mg /
Hydrochloride 100 ml
Tablets 250 mg,
500 mg
*
*
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
6 * Complementary
Co-Trimoxazole U Tablets 40 + 200 mg
(Trimethoprim + 80 + 400 mg
Sulphamethoxazole) Suspension 40 +
200 mg / 5 ml
Doxycycline U Capsules 100 mg
Erythromycin U Syrup 125 mg / 5 ml
Estolate Tablets 250 mg,
500 mg.
Gentamicin U Injection 10 mg / ml
40 mg / ml
Metronidazole U Tablets 200 mg,
400 mg
Injection 500 mg /
100 ml
Nalidixic Acid U Tablets 250 mg,
500 mg
Nitrofurantoin U Tablets 100 mg
Norfloxacin U Tablets 400 mg
Roxithromycin* S, T Tablets 50 mg,
150 mg
Sulphadiazine* S, T Tablets 500 mg
Tetracycline U Tablets or Capsules 250 mg
Vancomycin T Injection 500 mg, 1 g
Hydrochloride*
6.2.3 Antileprosy Medicines
Clofazimine S, T Capsules 50 mg,
100 mg
Dapsone U Tablets 50 mg,
100 mg
Rifampicin U Capsules or Tablets 150 mg,
300 mg
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
* Complementary 7
6.2.4 Antituberculosis Medicines
Ethambutol U Tablets 200 mg,
400 mg,
600 mg,
800 mg
Isoniazid U Tablets 50 mg,
100 mg,
300 mg
Ofloxacin* S, T Tablets 100 mg,
200 mg
Syrup 50 mg / 5 ml
Pyrazinamide U Tablets 500 mg,
750 mg,
1000 mg,
1500 mg
Rifampicin U Capsules/Tablets 50 mg,
150 mg,
300 mg,
450 mg
Syrup 100 mg / 5 ml
Streptomycin U Injection 0.75 g, 1 g
Sulphate
Thiacetazone + S, T Tablets 150 mg +
Isoniazid 300 mg
6.3 Antifungal Medicines
Amphotericin B S, T Injection 50 mg
Clotrimazole U Pessaries 100 mg
200 mg
Gel 2%
Fluconazole S, T Capsules or Tablets 50 mg,
100 mg,
150 mg,
200 mg
Flucytosine S, T Capsules 250 mg
Griseofulvin U Capsules or Tablets 125 mg,
250 mg
Ketoconazole S, T Tablets 200 mg
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
8 * Complementary
Nystatin U Tablets 500,000 IU
Pessaries 100,000 IU
6.4 Antiviral Medicines
6.4.1 Antiherpes Medicines
Acyclovir S, T Tablets 200 mg,
400 mg
Injection 250 mg,
500 mg
Suspension 400 mg / 5 ml
6.4.2 Antiretroviral Medicines*
6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors
Didanosine* S, T Tablets 250 mg
400 mg
Lamivudine* S, T Tablets 150 mg
Lamivudine +
Nevirapine +
Stavudine* S, T Tablets 150 mg +
200 mg
+ 30 mg
Lamivudine +
Zidovudine* S, T Tablets 150 mg +
300 mg
Stavudine* S, T Capsules 15 mg,
30 mg,
40 mg
Zidovudine* S, T Tablets 100 mg
300 mg
6.4.2.2 Non-nucleoside Reverse Transcriptase Inhibitors
Efavirenz* S, T Capsules 200 mg
600 mg
Nevirapine* S, T Capsules 200 mg
Suspension 50 mg / 5 ml
6.4.2.3 Protease Inhibitors
Indinavir* S, T Capsules 200 mg,
400 mg
Nelfinavir* S, T Capsules 250 mg
*
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
* Complementary 9
Ritonavir* S, T Capsules 100 mg
Syrup 400 mg / ml
Saquinavir* S, T Capsules 200 mg
6.5 Antiprotozoal Medicines
6.5.1 Antiamoebic and Antigiardiasis Medicines
Diloxanide Furoate U Tablets 500 mg
Metronidazole U Tablets 200 mg,
400 mg
Injection 500 mg /
100 ml
Tinidazole U Tablets 500 mg
6.5.2 Antileishmaniasis Medicines
Amphotericin B S, T Injection 50 mg
Pentamidine S, T Injection 200 mg
Isothionate
Sodium
Stibogluconate S, T Injection 100 mg / ml
6.5.3 Antimalarial Medicines
6.5.3.1 For Curative Treatment
Artesunate T Injection 60 mg
Chloroquine U Tablets 150 mg
Phosphate base
Injection 40 mg / ml
Syrup 50 mg / 5 ml
Primaquine U Tablets 2.5 mg,
7.5 mg
Pyrimethamine U Tablets 25 mg
Quinine U Tablets 300 mg
Sulphate S, T Injection 300 mg / ml
Sulfadoxine +
Pyrimethamine U Tablets 500 mg +
25 mg
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
10 * Complementary
6.5.3.2 For Prophylaxis
Chloroquine U Tablets 150 mg
Phosphate base
Syrup 50 mg / 5 ml
6.5.4 Antipneumocystosis and Antitoxoplasmosis Medicines
Co-Trimoxazole U Tablets 40 + 200 mg
(Trimethoprim + 80 + 400 mg
Sulphamethoxazole) Suspension 40 +
200 mg / 5 ml
Pentamidine S, T Injection 200 mg
Isothionate
Trimethoprim U Tablets 100 mg
7. Antimigraine Medicines
7.1 For Treatment of Acute Attack
Acetyl Salicylic Acid U Tablets 300 – 350 mg
Dihydroergotamine S, T Tablets 1 mg
Paracetamol U Tablets 500 mg
7.2 For Prophylaxis
Propranolol U Tablets 10 mg, 40 mg
Hydrochloride
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
11
8. Antineoplastic, Immunosuppressives and Medicines
used in Palliative Care
8.1 Immunosuppressive Medicines
Azathioprine* T Tablets 50 mg
Cyclosporine T Capsules 10 mg,
25 mg,
50 mg,
100 mg
Concentrate for Injection 100 mg / ml
8.2 Cytotoxic Medicines
Actinomycin D* T Injection 0.5 mg
Alpha Interferon* T Injection 3 million IU
Bleomycin* T Injection 15 mg
Busulphan* T Tablets 2 mg
Cisplatin* T Injection 10 mg / vial
50 mg / vial
Cyclophosphamide* T Tablets 50 mg
Injection 200 mg
500 mg
Cytosine
Arabinoside* T Injection 100 mg / vial
500 mg / vial
1000 mg / vial
Danazol* T Capsules 50 mg,
100 mg
Doxorubicin* T Injection 10 mg
50 mg
Etoposide* T Capsules 100 mg
Injection 100 mg / 5 ml
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
12 * Complementary
Flutamide* T Tablet 250 mg
5-Fluorouracil* T Injection 250 mg / 5 ml
Folinic Acid* T Injection 3 mg / ml
Gemcitabine T Injection 200 mg
Hydrochloride* 1 g
L- Asparaginase* T Injection 10000 KU
Melphalan* T Tablets 2 mg, 5 mg
Mercaptopurine* T Tablets 50 mg,
Injection 100 mg / ml
Methotrexate* T Tablets 2.5 mg
Injection 50 mg / ml
Mitomycin-C* T Injection 10 mg
Paclitaxel* T Injection 30 mg / 5 ml
Procarbazine* T Capules 50 mg
Vinblastine T Injection 10 mg
Sulphate*
Vincristine T Injection 1 mg / ml
8.3 Hormones and Antihormones
Prednisolone* S, T Tablets 5 mg
Injection 20 mg
25 mg (as
sodium
phosphate or
succinate)
Raloxifene* T Tablets 60 mg
Tamoxifen T Tablets 10 mg, 20 mg
Citrate*
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
* Complementary 13
8.4 Medicines used in Palliative Care
Morphine Sulphate* T Tablets 10 mg
Ondansetron* S, T Tablets 4 mg, 8 mg
Injection 2 mg / ml
Syrup 2 mg / 5 ml
9. Antiparkinsonism Medicines
Bromocriptine S, T Tablets 1.25 mg,
Mesylate 2.5 mg
Levodopa+
Carbidopa U Tablets 100 mg +
10 mg
250 mg +
25 mg
100 mg +
25 mg
Trihexyphenidyl U Tablets 2 mg
Hydrochloride
10. Medicines affecting the Blood
10.1 Antianemia Medicines
Cyanocobalamin U Injection 1 mg / ml
Ferrous Salt U Tablets Equivalent to
60 mg
elemental
iron
Oral solution 25 mg
elemental
iron (as
sulphate) / ml
Folic Acid U Tablets 1 mg, 5 mg
Iron Dextran S, T Injection 50 mg
iron/ ml
Pyridoxine U Tablets 5 mg
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
14 * Complementary
10.2 Medicines Affecting Coagulation
Acenocoumarol
4 mg
Heparin Sodium S, T Injection 1000 IU / ml
5000 IU / ml
Menadione
Sodium Sulphite S, T Tablets 10 mg
Protamine Sulphate S, T Injection 10 mg / ml
Phytomenadione S, T Injection 10 mg / ml
Warfarin S, T Tablets 5 mg
Sodium
11. Blood Products and Plasma Substitutes
11.1 Plasma Substitutes
Dextran-40 U Injection 10%
Dextran-70 U Injection 6%
Fresh
Frozen Plasma* T Injection
Hydroxyethyl Starch S, T Injection 6%
(Hetastarch)
Polygeline S, T Injection 3.5%
11.2 Plasma Fractions for Specific Use
Albumin S, T Injection 5%, 20%
Cryoprecipitate S, T Injection
Factor VIII
Concentrate* S, T Injection Dried
Factor IX Complex
(Coagulation
Factors II,VII, IX, X)
* S, T Tablets 1 mg, 2 mg,
* S, T Injection Dried
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
* Complementary 15
Platelet Rich PlasmaS, T Injection
12. Cardiovascular Medicines
12.1 Antianginal Medicines
Acetyl Salicylic Acid*U Tablets 75 mg,
100 mg
350 mg
Diltiazem S, T Tablets 30 mg, 60 mg
Glyceryl Trinitrate U Sublingual Tablets 0.5 mg
Injection 5 mg / ml
Isosorbide 5
Mononitrate/DinitrateU Tablets 10 mg, 20 mg
Metoprolol* U Tablets 25 mg, 50 mg
Injection 1 mg/ ml
Propranolol U Tablets 10 mg, 40 mg
Injection 1 mg / ml
12.2 Antiarrhythmic Medicines
Adenosine* S, T Injection 3mg / ml
Amiodarone S, T Tablets 100 mg,
200 mg
Injection 150 mg
Bretylium Tosylate* T Injection 1 mg, 2 mg
4 mg / ml
Diltiazem S, T Tablets 30 mg, 60 mg
Diltiazem T Injection 5 mg/ ml
Esmolol* T Injection 10 mg / ml
Isoprenaline T Injection 2 mg / ml
Hydrochloride*
Lignocaine S, T Injection 1%, 2%
Hydrochloride
Mexiletine S, T Capsules, 50 mg,
Hydrochloride 150 mg
Injection 25 mg / ml
Procainamide T Tablets 250 mg
Hydrochloride Injection 100 mg / ml
*
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
16 * Complementary
Quinidine T Tablets 100 mg
Verapamil S, T Tablets 40 mg, 80 mg
Injection 2.5 mg / ml
12.3 Antihypertensive Medicines
Amlodipine U Tablets 2.5 mg, 5 mg,
10 mg
Atenolol U Tablets 50 mg
100 mg
Chlorthalidone* U Tablets 25 mg,
50 mg
Clonidine S, T Tablets 100 mg
Hydrochloride* 150 mg
Enalapril U Tablets 2.5 mg,
Maleate 5 mg,
10 mg
Injection 1.25 mg / ml
Losartan S, T Tablets 25 mg, 50 mg
Potassium*
Methyldopa U Tablets 250 mg
Nifedipine S, T Capsules 5 mg,
10 mg
Tablets 10 mg,
20 mg,
Sustained release capsules 10 mg,
or tablets 20 mg,
Propranolol U Tablets 10 mg,
40 mg
Sodium
Nitroprusside
Terazosin* S, T Tablets 1 mg, 2 mg,
5 mg
* T Injection 50 mg/ 5 ml
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
* Complementary 17
12.4 Medicines used in Heart Failure
Digoxin S, T Tablets 0.25 mg
Injection 0.25 mg / ml
Elixir 0.05 mg / ml
Dobutamine
Dopamine S,T Injection 40 mg / ml
Hydrochloride
12.5 Antithrombotic Medicines
Acetyl Salicylic Acid U Tablets 75 mg,
100 mg
Heparin S, T Injection 1000 IU / ml
Sodium* 5000 IU / ml
Streptokinase 750,000 IU
Urokinase T Injection 500,000
IU / ml
10,00,000
IU / ml
13. Dermatological Medicines (Topical)
13.1 Antifungal Medicines
Benzoic Acid +
Salicylic Acid U Ointment or Cream 6% + 3%
Miconazole U Ointment or Cream 2%
13.2 Antiinfective Medicines
Acyclovir S, T Cream 5%
Framycetin SulphateU Cream 0.5%
Methylrosanilinium
Chloride
(Gentian Violet) U Aqueous solution 0.5%
* S, T Injection 50 mg / ml
* S, T Injection
15,00,000 IU
*
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
18 * Complementary
Neomycin +
Bacitracin U Ointment 5 mg + 500 IU
Povidone Iodine U Solution or Ointment 5%
Silver Nitrate U Lotion 10%
Silver
Sulphadiazine U Cream 1%
13.3 Antiinflammatory and Antipruritic Medicines
Betamethasone U Cream / Ointment 0.05%
Dipropionate
Calamine U Lotion
13.4 Astringent Medicines
Zinc Oxide U Dusting Powder
13.5 Medicines Affecting Skin Differentiation and Proliferation
Coal Tar U Solution 5%
Dithranol* T Ointment 0.1-2%
Glycerin U Solution
Salicylic Acid U Solution 5%
13.6 Scabicides and Pediculicides
Benzyl Benzoate U Lotion 25%
Gamma
Benzene
Hexachloride U Lotion 1%
14. Diagnostic Agents
14.1 Ophthalmic Medicines
Fluorescein S, T Eye drops 1%
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
* Complementary 19
Lignocaine S, T Eye Drops 4%
Tropicamide S, T Eye drops 1%
14.2 Radiocontrast Media
Barium Sulphate S, T Suspension 100% w/v
250% w/v
Calcium Ipodate S, T Injection 3 g
Iopanoic Acid S, T Tablets 500 mg
Meglumine
Iothalamate S, T Injection 60% w/v
(iodine =
280 mg / ml)
Meglumine Iotroxate S, T Solution 5-8 g
iodine in
100-250 ml
Propyliodone S, T Oily, suspension 500-
600 mg / ml
Sodium Iothalamate S, T Injection 70% w/v
(Iodine =
420 mg / ml)
Sodium S, T Injection 60% w/v
Meglumine (Iodine
Diatrizoate conc. =
292 mg / ml)
76% w/v
(Iodine
conc. =
370 mg / ml)
15. Disinfectants and Antiseptics
15.1 Antiseptics
Acriflavin+Glycerin U Solution
Benzoin Compound U Tincture
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
20
Cetrimide U Solution 20% (conc.
for dilution)
Chlorhexidine U Solution 5% (conc.
for dilution)
Ethyl Alcohol 70% U Solution
Gentian Violet U Paint 0.5%, 1%
Hydrogen Peroxide U Solution 6%
Povidone Iodine U Solution 5%, 10%
15.2 Disinfectants
Bleaching Powder U Powder
Formaldehyde IP U Solution
Glutaraldehyde S,T Solution 2%
Potassium
Permanganate U Crystals for solution
16. Diuretics
Furosemide U Injection, 10 mg/ ml,
Tablets 40 mg
Hydrochlorothiazide U Tablets 25 mg, 50 mg
Mannitol* U Injection 10%, 20%
Spironolactone U Tablets 25 mg
17. Gastrointestinal Medicines
17.1 Antacids and other Antiulcer Medicines
Aluminium U Tablet
Hydroxide + Suspension
Magnesium
Hydroxide
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
* Complementary 21
Omeprazole U Capsules 10 mg,
20 mg, 40 mg
Ranitidine U Tablets 150 mg,
Hydrocholoride 300 mg
Injection 25 mg / ml
17.2 Antiemetics
Domperidone U Tablets 10 mg
Syrup 1 mg / ml
Metoclopramide U Tablets 10 mg
Syrup 5 mg / ml
Injection 5 mg / ml
Prochlorperazine U Tablets 5 mg, 25 mg
Promethazine U Tablets 10 mg, 25 mg
Elixir or Syrup 5 mg / 5 ml
Injection 25 mg / ml
17.3 Antihaemorrhoidal Medicines
Local Anaesthetic, U Ointment /suppository
Astringent and
Antiinflammatory Medicines
17.4 Antiinflammatory Medicines
Sulfasalazine T Tablets 500 mg
17.5 Antispasmodic Medicines
Dicyclomine U Tablets 10 mg
Hydrochloride Injection 10 mg / ml
Hyoscine
Butyl Bromide U Tablets or 10 mg
Injection 20 mg / ml
17.6 Laxatives
Bisacodyl U Tablets/ suppository 5 mg
Isphaghula U Granules
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
22
17.7 Medicines used in Diarrhoea
17.7.1 Oral U Powder for solution As per IP
Rehydration Salts
17.7.2 Antidiarrhoeal Medicines
Furazolidone S, T Tablets 100 mg
Syrup 25 mg / 5 ml
Loperamide* S, T Capsules 2 mg
(Contraindicated
for paediatric use)
18. Hormones, other Endocrine Medicines and
Contraceptives
18.1 Adrenal Hormones and Synthetic Substitutes
Dexamethasone S, T Tablets 0.5 mg
Injection 4 mg / ml
Hydrocortisone U Injection 100 mg / ml
Sodium Succinate
Methylprednisolone S, T Injection 40 mg/ ml
Prednisolone U Tablets 5 mg, 10 mg
18.2 Androgens
Testosterone T Capsules 40 mg (as
undecanoate)
T Injection 25 mg / ml
(as
propionate)
18.3 Contraceptives
18.3.1 Hormonal Contraceptives
Ethinylestradiol + U Tablets .03 mg +
Levonorgesterol 0.15 mg
Ethinylestradiol +
Norethisterone U Tablets 0.035 mg +
1.0 mg
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
* Complementary 23
Hormone
Releasing IUD T Levonorgesterol Releasing IUD
18.3.2 Intrauterine Devices
IUD containing
Copper U
18.3.3 Barrier Methods
Condoms U
18.3.4. Non Hormonal Contraceptives
Centchroman U Tablets 30 mg
18.4 Estrogens
Ethinylestradiol U Tablets 0.01 mg,
0.05 mg
18.5 Antidiabetics and Hyperglycaemics
18.5.1 Insulins and Other Antidiabetic Agents
Glibenclamide U Tablets 2.5 mg, 5 mg
Insulin Injection
(Soluble) U Injection 40 IU / ml
Intermediate Acting U Injection 40 IU / ml
Insulin (Lente/NPH
Insulin)
Metformin U Tablets 500 mg
18.5.2 Hyperglycaemics
Glucagon* T Injection 1 mg / ml
18.6 Ovulation Inducers
Clomiphene T Tablets 25 mg,
Citrate* 50 mg
100 mg
18.7 Progestogens
Medroxy U Tablets 5 mg, 10 mg
Progesterone
Acetate
Norethisterone U Tablets 5 mg
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
24 * Complementary
18.8 Thyroid and Antithyroid Medicines
Carbimazole S, T Tablets 5 mg, 10 mg
Levothyroxine S, T Tablets 0.1 mg
Iodine S, T Solution 8 mg / 5 ml
19. Immunologicals
19.1 Diagnostic Agents
Tuberculin, Purified U Injection
Protein Derivative
19.2 Sera and Immunoglobulins
Anti-D S, T Injection 250 mg, 300 mg
Immunoglobulin
(Human)
Antisnake Venom U Injection 10 ml
Antitetanus Human U Injection 250 IU, 500 IU
Immunoglobin
Diphtheria Antitoxin S, T Injection 10,000 IU
Rabies U Injection 150 IU / ml
Immunoglobulin
19.3 Vaccines
19.3.1 For Universal Immunisation
B.C.G Vaccine U Injection
D.P.T Vaccine U Injection
Hepatitis B Vaccine U Injection
Measles Vaccine U Injection
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
25
Oral Poliomyelitis U Solution
Vaccine (Live
Attenuated)
19.3.2 For Specific Group of Individuals
Rabies Vaccine U Injection
Tetanus Toxoid U Injection
20. Muscle Relaxants (peripherally acting) and
Cholinesterase Inhibitors
Atracurium S, T Injection 10 mg / ml
Besylate*
Neostigmine S, T Tablets 15 mg
Injection 0.5 mg/ ml
Pancuronium S, T Injection 2 mg/ml
Bromide
Pyridostigmine S, T Tablet 60 mg
Bromide Injection 1 mg / ml
Succinyl Choline S, T Injection 50 mg/ ml
Chloride
21. Ophthalmological Preparations
21.1 Antiinfective Agents
Chloramphenicol U Drops/Ointment 0.4%, 1%
Ciprofloxacin U Drops/Ointment 0.3%
Hydrochloride
Gentamicin U Drops 0.3%
Miconazole U Drops 1%
Povidone Iodine S, T Drops 0.6%
Sulphacetamide U Drops 10%,
Sodium 20%,30%
Tetracycline U Ointment 1%
Hydrochloride
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
26 * Complementary
21.2 Antiinflammatory Agents
Prednisolone U Drops 0.1%
Acetate
Prednisolone U Drops 1%
Sodium Phosphate
Xylometazoline U Drops 0.05%, 0.1%
21.3 Local Anaesthetics
Tetracaine U Drops 0.5%
Hydrochloride
21.4 Miotics and Antiglaucoma Medicines
Acetazolamide S, T Tablets 250 mg
Betaxolol S, T Drops 0.25%, 0.5%
Hydrochloride
Physostigmine S, T Drops 0.25 %
Salicylate*
Pilocarpine S, T Drops 2%, 4%
Timolol Maleate S, T Drops 0.25%, 0.5%,
21.5 Mydriatics
Atropine Sulphate U Drops/Ointment 1%
Homatropine U Drops 2%
Phenylephrine U Drops 5%
21.6 Ophthalmic Surgical Aids
Methyl Cellulose* T Injection 2%
22. Oxytocics and Antioxytocics
22.1 Oxytocics
Methyl Ergometrine U Tablets 0.125 mg
Injection 0.2 mg / ml
Mifepristone T Tablets 200 mg
Oxytocin S, T Injection 5 IU / ml,
10 IU / ml
22.2 Antioxytocics
Isoxsuprine S, T Tablets 10 mg
Hydrochloride Injection 5 mg / ml
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
* Complementary 27
Terbutaline S, T Tablets 2.5 mg
Sulphate Injection 0.5 mg / ml
23. Peritoneal Dialysis Solution
Intraperitoneal Dialysis Solution (of approximate composition)
24. Psychotherapeutic Medicines
24.1 Medicines used in Psychotic Disorders
Chlorpromazine U Tablets 25 mg,
Hydrochloride 50 mg,
100 mg
Syrup 25 mg / 5 ml
Injection 25 mg / ml
Haloperidol S, T Tablets 1.5 mg, 5 mg,
10 mg
Injection 5 mg / ml
Trifluoperazine S, T Tablet 5 mg, 10 mg
24.2 Medicines used in Mood Disorders
24.2.1 Medicines used in Depressive Disorders
Amitriptyline U Tablets 25 mg
Fluoxetine U Capsules 20 mg
Hydrochloride
Imipramine U Tablets 25 mg, 75 mg
24.2.2 Medicines used in Bipolar Disorders
Lithium Carbonate T Tablets 150 mg
24.3 Medicines used for Generalized Anxiety and Sleep Disorders
Alprazolam U Tablets 0.25 mg,
0.5 mg
Diazepam U Tablets 2 mg,
5 mg,
10 mg
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
28
Nitrazepam U Tablets 5 mg, 10 mg
24.4 Medicines used for Obsessive Compulsive Disorders and Panic
Attacks
Clomipramine S, T Tablets 10 mg,
Hydrochloride 25 mg
25. Medicines Acting on the Respiratory Tract
25.1 Antiasthmatic Medicines
Aminophylline U Injection 25 mg / ml
Beclomethasone U Inhalation 50 mg,
Dipropionate 250 mg/dose
Hydrocortisone U Injection 100 mg,
Sodium Succinate 200 mg,
400 mg
Salbutamol U Tablets 2 mg, 4 mg
Sulphate Syrup 2 mg / 5 ml
Inhalation 100 mg / dose
Theophylline U Tablets 100 mg,
Compounds 200 mg
25.2 Antitussives
Codeine U Tablets 10 mg
Phosphate Syrup 15 mg / 5 ml
Dextromethorphan U Tablets 30 mg
26. Solutions correcting Water, Electrolyte and Acid-Base
Disturbances
26.1 Oral
Oral
Rehydration Salts U Powder for Solution As per IP
26.2 Parenteral
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
29
Glucose U Injection 5% isotonic
50%
hypertonic
Glucose with U Injection 5% + 0.9%
Sodium Chloride
Normal Saline U Injection 0.9%
N/2 Saline S, T Injection
N/5 Saline S, T Injection
Potassium Chloride U Injection 11.2% Sol.
Ringer Lactate U Injection
Sodium Bicarbonate U Injection
26.3 Miscellaneous
Water for Injection U Injection 2 ml, 5 ml,
10 ml
27. Vitamins and Minerals
Ascorbic Acid U Tablets 100 mg,
500 mg
Calcium salts U Tablets 250 mg,
500 mg
Multivitamins U Tablets
(As per Schedule V)
Nicotinamide U Tablets 50 mg
Pyridoxine U Tablets 25 mg
Riboflavine U Tablets 5 mg
Thiamine U Tablets 100 mg
Vitamin A U Tablets 5000 IU,
Capsules 10,000 IU
50,000 IU
Injection 50,000 IU / ml
Vitamin D3
(Ergocalciferol) S, T Capsules 0.25 mg, 1 mg
30
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Medicine Category Route of Administration/ Strengths
Dosage Form
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
31
Index
A
1. Acenocoumarol 15
2. Acetazolamide 27
3. Acetyl Salicylic Acid 2, 11, 16, 18
4. Acriflavin+Glycerin 20
5. Actinomycin D 12
6. Activated Charcoal 3
7. Acyclovir 9, 18
8. Adenosine 16
9. Adrenaline Bitartrate 3
10. Albendazole 5
11. Albumin 15
12. Allopurinol 2
13. Alpha Interferon 12
14. Alprazolam 28
15. Aluminium Hydroxide + Magnesium Hydroxide 21
16. Amikacin 6
17. Aminophylline 29
18. Amiodarone 16
19. Amitriptyline 28
20. Amlodipine 17
21. Amoxicillin 5
22. Amphotericin B 8, 10
23. Ampicillin 5
24. Antisnake Venom 4, 25
25. Anti-D Immunoglobulin (Human) 25
26. Antitetanus Human Immunoglobin 25
27. Artesunate 10
28. Ascorbic Acid 30
29. Atenolol 17
30. Atracurium Besylate 26
31. Atropine Sulphate 1, 3, 27,
32. Azathioprine 3, 12
33. Azithromycin 6
B
34. B.C.G Vaccine 25
35. Barium Sulphate 20
36. Beclomethasone Dipropionate 29
37. Benzathine Benzylpenicillin 5
38. Benzoic Acid + Salicylic Acid 18
39. Benzoin Compound 20
Sl. No. Medicine Page No.
40. Benzyl Benzoate 19
41. Benzylpenicillin 6
42. Betamethasone Dipropionate 19
43. Betaxolol Hydrochloride 27
44. Bisacodyl 22
45. Bleaching Powder 21
46. Bleomycin 12
47. Bretylium Tosylate 16
48. Bromocriptine Mesylate 14
49. Bupivacaine Hydrochloride 1
50. Busulphan 12
C
51. Calamine 19
52. Calcium Gluconate 4
53. Calcium Ipodate 20
54. Calcium salts 30
55. Carbamazepine 4
56. Carbimazole 25
57. Cefotaxime 6
58. Ceftazidime 6
59. Ceftriaxone 6
60. Cefuroxime 6
61. Centchroman 24
62. Cephalexin 6
63. Cetrimide 21
64. Chloramphenicol 6, 26
65. Chlorhexidine 21
66. Chloroquine Phosphate 3, 10, 11
67. Chlorpheniramine Maleate 3
68. Chlorpromazine Hydrochloride 28
69. Chlorthalidone 17
70. Ciprofloxacin Hydrochloride 6, 26
71. Cisplatin 12
72. Clarithromycin 6
73. Clofazimine 7
74. Clomiphene Citrate 24
75. Clomipramine Hydrochloride 29
76. Clonidine Hydrochloride 17
77. Clotrimazole 8
78. Cloxacillin 6
79. Coal Tar 19
80. Codeine Phosphate 29
81. Colchicine 2
32
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Sl. No. Medicine Page No.
82. Condoms 24
83. Co-Trimoxazole (Trimethoprim + Sulphamethoxazole) 7, 11
84. Cryoprecipitate 15
85. Cyanocobalamin 14
86. Cyclophosphamide 12
87. Cyclosporine 12
88. Cytosine Arabinoside 12
D
89. D.P.T Vaccine 25
90. Danazol 12
91. Dapsone 7
92. Desferrioxamine Mesylate 4
93. Dexamethasone 3, 23
94. Dexchlorpheniramine Maleate 3
95. Dextran-40 15
96. Dextran-70 15
97. Dextromethorphan 29
98. Diazepam 1, 4, 28
99. Diclofenac 2
100. Dicyclomine Hydrochloride 22
101. Didanosine 9
102. Diethylcarbamazine Citrate 5
103. Digoxin 18
104. Dihydroergotamine 11
105. Diloxanide Furoate 10
106. Diltiazem 16
107. Dimercaprol 4
108. Diphtheria Antitoxin 25
109. Dithranol 19
110. Dobutamine 18
111. Domperidone 22
112. Dopamine Hydrochloride 18
113. Doxapram 2
114. Doxorubicin 12
115. Doxycycline 7
E
116. Efavirenz 9
117. Enalapril Maleate 17
118. Erythromycin Estolate 7
119. Esmolol 16
33
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Sl. No. Medicine Page No.
120. Ethambutol 8
121. Ether, Anaesthetic 1
122. Ethinylestradiol + Levonorgesterol 23
123. Ethinylestradiol + Norethisterone 23
124. Ethinylestradiol 24
125. Ethyl Alcohol 70% 21
126. Ethyl Chloride 1
127. Etoposide 12
F
128. 5-Fluorouracil 13
129. Factor IX Complex (Coagulation Factors II,VII, IX, X)* 15
130. Factor VIII Concentrate 15
131. Ferrous Salt 14
132. Fluconazole 8
133. Flucytosine 8
134. Flumazenil 4
135. Fluorescein 19
136. Fluoxetine Hydrochloride 28
137. Flutamide 13
138. Folic Acid 14
139. Folinic Acid 13
140. Formaldehyde IP 21
141. Framycetin Sulphate 18
142. Fresh Frozen Plasma 15,
143. Furazolidone 23
144. Furosemide 21
G
145. Gamma Benzene Hexachloride 19
146. Gemcitabine Hydrochloride 13
147. Gentamicin 7, 26
148. Gentian Violet 21
149. Glibenclamide 24
150. Glucagon 24
151. Glucose with Sodium Chloride 30
152. Glucose 30
153. Glutaraldehyde 21
154. Glycerin 19
155. Glyceryl Trinitrate 16
156. Griseofulvin 8
H
34
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Sl. No. Medicine Page No.
157. Haloperidol 28
158. Halothane 1
159. Heparin Sodium 15, 18
160. Hepatitis B Vaccine 25
161. Homatropine 27
162. Hormone Releasing IUD 24
163. Hydrochlorothiazide 21
164. Hydrocortisone Sodium Succinate 3, 23, 29
165. Hydrogen Peroxide 21
166. Hydroxyethyl Starch (Hetastarch) 15
167. Hyoscine Butyl Bromide 22
I
168. Ibuprofen 2
169. Imipramine 28
170. Indinavir 9
171. Insulin Injection (Soluble) 24
172. Intermediate Acting Insulin (Lente/NPH Insulin) 24
173. Intraperitoneal Dialysis Solution
(of approximate composition) 28
174. Iodine 25
175. Iopanoic Acid 20
176. Iron Dextran 14
177. Isoflurane 1
178. Isoniazid 8
179. Isoprenaline Hydrochloride 16
180. Isosorbide 5 Mononitrate/Dinitrate 16
181. Isoxsuprine Hydrochloride 27
182. Isphaghula 22
183. IUD containing Copper 24
K
184. Ketamine Hydrochloride 1
185. Ketoconazole 8
L
186. L- Asparaginase 13
187. Lamivudine + Zidovudine 9
188. Lamivudine +Nevirapine + Stavudine 9
189. Lamivudine 9
190. Levodopa+ Carbidopa 14
191. Levothyroxine 25
192. Lignocaine Hydrochloride + Adrenaline 1
35
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Sl. No. Medicine Page No.
193. Lignocaine Hydrochloride 1, 16
194. Lignocaine 20
195. Lithium Carbonate 28
196. Local Anaesthetic, Astringent and 22
Antiinflammatory Medicines
197. Loperamide (Contraindicated for paediatric use) 23
198. Losartan Potassium 17
M
199. Magnesium Sulphate 4
200. Mannitol 21
201. Measles Vaccine 25
202. Mebendazole 5
203. Medroxy Progesterone Acetate 24
204. Meglumine Iothalamate 20
205. Meglumine Iotroxate 20
206. Melphalan 13
207. Menadione Sodium Sulphite 15
208. Mercaptopurine 13
209. Metformin 24
210. Methotrexate 3, 13
211. Methyl Cellulose 27
212. Methyl Ergometrine 27
213. Methyldopa 17
214. Methylprednisolone 23
215. Methylrosanilinium Chloride (Gentian Violet) 18
216. Methylthioninium Chloride (Methylene blue) 4
217. Metoclopramide 22
218. Metoprolol 16
219. Metronidazole 7, 10
220. Mexiletine Hydrochloride 16
221. Miconazole 18, 26
222. Midazolam 2
223. Mifepristone 27
224. Mitomycin-C 13
225. Morphine Sulphate 2, 14
226. Multivitamins 30
N
227. N/2 Saline 30
228. N/5 Saline 30
229. Nalidixic Acid 7
230. Naloxone 4
231. Nelfinavir 9
36
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Sl. No. Medicine Page No.
232. Neomycin + Bacitracin 19
233. Neostigmine 26
234. Nevirapine 9
235. Niclosamide 5
236. Nicotinamide 30
237. Nifedipine 17
238. Nitrazepam 29
239. Nitrofurantoin 7
240. Nitrous Oxide 1
241. Norethisterone 24
242. Norfloxacin 7
243. Normal Saline 30
244. Nystatin 9
O
245. Ofloxacin 8
246. Omeprazole 22
247. Ondansetron 14
248. Oral Poliomyelitis Vaccine (Live Attenuated) 26
249. Oral Rehydration Salts 23, 29
250. Oxygen 1
251. Oxytocin 27
P
252. Paclitaxel 13
253. Pancuronium Bromide 26
254. Paracetamol 2, 11
255. Penicillamine 4
256. Pentamidine Isothionate 10, 11
257. Pentazocine 2
258. Pethidine Hydrochloride 2
259. Pheniramine Maleate 3
260. Phenobarbitone 4
261. Phenylephrine 27
262. Phenytoin Sodium 4
263. Physostigmine Salicylate 27
264. Phytomenadione 15
265. Pilocarpine 27
266. Platelet Rich Plasma 16
267. Polygeline 15
268. Potassium Chloride 30
269. Potassium Permanganate 21
270. Povidone Iodine 19, 21
37
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Sl. No. Medicine Page No.
271. Pralidoxime Chloride (2-PAM) 4
272. Praziquantel 5
273. Prednisolone 3, 13, 23
274. Prednisolone Acetate 27
275. Prednisolone Sodium Phosphate 27
276. Primaquine 10
277. Procainamide Hydrochloride 16
278. Procaine Benzylpenicillin 6
279. Procarbazine 13
280. Prochlorperazine 22
281. Promethazine 2, 3, 22
282. Propranolol Hydrochloride 11
283. Propranolol 16, 17
284. Propyliodone 20
285. Protamine Sulphate 15
286. Pyrantel Pamoate 5
287. Pyrazinamide 8
288. Pyridostigmine Bromide 26
289. Pyridoxine 14, 30
290. Pyrimethamine 10
Q
291. Quinidine 17
292. Quinine Sulphate 10
R
293. Rabies Immunoglobulin 25
294. Rabies Vaccine 26
295. Raloxifene 13
296. Ranitidine Hydrocholoride 22
297. Riboflavin 30
298. Rifampicin 7, 8
299. Ringer Lactate 30
300. Ritonavir 10
301. Roxithromycin 7
S
302. Salbutamol Sulphate 29
303. Salicylic Acid 19
304. Saquinavir 10
305. Silver Nitrate 19
306. Silver Sulphadiazine 19
38
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Sl. No. Medicine Page No.
307 Sodium Meglumine Diatrizoate 20
308. Sodium Bicarbonate 30
309. Sodium Iothalamate 20
310. Sodium Nitrite 4
311. Sodium Nitroprusside* 17
312. Sodium Stibogluconate 10, 11
313. Sodium Thiosulphate 4
314. Sodium Valproate 5
315. Spironolactone 21
316. Stavudine 9
317. Streptokinase 18
318. Streptomycin Sulphate 8
319. Succinyl Choline Chloride 26
320. Sulfadoxine +Pyrimethamine 10
321. Sulfasalazine 3, 22
322. Sulphacetamide Sodium 26
323. Sulphadiazine 7
T
324. Tamoxifen Citrate 13
325. Terazosin 17
326. Terbutaline Sulphate 28
327. Testosterone 23
328. Tetanus Toxoid 26
329. Tetracaine Hydrochloride 27
330. Tetracycline Hydrochloride 26
331. Tetracycline 7
332. Theophylline Compounds 29
333. Thiacetazone + Isoniazid 8
334. Thiamine 30
335. Thiopentone Sodium 1
336. Timolol Maleate 27
337. Tinidazole 10
338. Trifluoperazine 28
339. Trihexyphenidyl Hydrochloride 14
340. Trimethoprim 11
341. Tropicamide 20
342. Tuberculin, Purified Protein Derivative 25
39
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
Sl. No. Medicine Page No.
U
343. Urokinase 18
V
344. Vancomycin Hydrochloride 7
345. Verapamil 17
346. Vinblastine Sulphate 13
347. Vincristine 13
348. Vitamin A 30
349. Vitamin D3 (Ergocalciferol) 30
W
350. Warfarin Sodium 15
351. Water for Injection 30
X
352. Xylometazoline 27
Z
353. Zidovudine 9
354. Zinc Oxide 19
NATIONAL LIST OF ESSENTIAL MEDICINES 2003
40

एक उत्तर दें

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / बदले )

Twitter picture

You are commenting using your Twitter account. Log Out / बदले )

Facebook photo

You are commenting using your Facebook account. Log Out / बदले )

Google+ photo

You are commenting using your Google+ account. Log Out / बदले )

Connecting to %s

%d bloggers like this: